The nitric oxide pathway and oxidative stress in heart failure

Congestive Heart Failure

Volumn 8, Issue 3, 2002, Pages

  Searles, Charles D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

CHRONIC DISEASE; DISEASE ASSOCIATION; HEART FAILURE; HEART FUNCTION; HUMAN; MOLECULAR INTERACTION; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIPHERAL CIRCULATION; REVIEW;

EID: 0036086936     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2002.00715.x     Document Type: Review

References (55)

1. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: Role of enhanced vascular superoxide production
2. Oxygen free radicals and heart failure
3. Evidence of oxidative stress in chronic heart failure in humans
4. Increased oxidative stress in patients with congestive heart failure
5. Elevated levels of 8-isoprostaglandin F2alpha in pericardial fluid of patients with heart failure: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure
6. Nitric oxide and cardiac function
7. Kinetics of cytochrome c2+ oxidation by peroxynitrite: Implications for superoxide measurements in nitric oxide-producing biological systems
8. 2: A pulse radiolysis study
9. Pathological implications of nitric oxide, superoxide, and peroxynitrite formation
10. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
11. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
12. Nitric oxide in excitable tissues: Physiological roles and disease
13. The L-arginine-nitric oxide pathway
14. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves
15. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle
16. Regulation of constitutive nitric oxide synthase activity by the human heart
17. Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium
18. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro
19. Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes
20. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha
21. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium
22. Nitric oxide attenuates cardiac myocyte contraction
23. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction
24. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
25. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone
26. Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle
27. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure
28. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
29. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure
30. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy
31. Increased nitric oxide production in heart failure
32. Nitric oxide synthase activities in human myocardium
33. Expression of inducible nitric oxide synthase in human heart failure
34. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy
35. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy
36. Increased production of nitric oxide in coronary arteries during congestive heart failure
37. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog
38. Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes
39. Alpha-adrenergic stimulation enhances inducible nitric oxide synthase expression in rat cardiac myocytes
40. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes
41. NF-kappa B and GTP cyclohydrolase regulate cytokine-induced nitric oxide production by cardiac myocytes
42. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B
43. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation
44. Basal release of nitric oxide is decreased in the coronary circulation in patients with heat failure
45. Endothelium-dependent vasodilation is attenuated in patients with heart failure
46. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure
47. Aorta and skeletal muscle NO synthase expression in experimental heart failure
48. Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure
49. Enhanced basal nitric oxide production in heart failure: Another failed counter-regulatory vasodilator mechanism
50. Tumor necrosis factor down-regulates an endothelial nitric oxide synthase mRNA by shortening its half-life
51. Endothelial function and dysfunction in heart failure
52. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase
53. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase
54. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure
55. Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo